Nasopharyngeal carcinoma—Review of the molecular mechanisms of tumorigenesis
暂无分享,去创建一个
L. You | D. Jablons | Yu-Ching Lin | B. He | Jae Y Kim | Zhidong Xu | J. Chou | Biao He
[1] F. He,et al. Functional polymorphisms and haplotypes in the promoter of the MMP2 gene are associated with risk of nasopharyngeal carcinoma , 2007, Human mutation.
[2] S. Tsao,et al. Latent membrane protein 1 of Epstein-Barr virus regulates p53 phosphorylation through MAP kinases. , 2007, Cancer letters.
[3] L. Chouchane,et al. Matrix metalloproteinase-1 (-1607) 1G/2G and -9 (-1562) C/T promoter polymorphisms: susceptibility and prognostic implications in nasopharyngeal carcinomas. , 2007, Clinica chimica acta; international journal of clinical chemistry.
[4] Rong Deng,et al. Silencing of LMP1 Induces Cell Cycle Arrest and Enhances Chemosensitivity Through Inhibition of AKT Signaling Pathway in EBV-Positive Nasopharyngeal Carcinoma Cells , 2007, Cell cycle.
[5] S. Tsao,et al. Latent membrane protein 1 suppresses RASSF1A expression, disrupts microtubule structures and induces chromosomal aberrations in human epithelial cells , 2007, Oncogene.
[6] M. Kashani-Sabet,et al. Wnt inhibitory factor-1 gene transfer inhibits melanoma cell growth. , 2007, Human gene therapy.
[7] Su-ping Zhao,et al. The Role of Enhanced Radiosensitivity and Tumor-specific Suicide Gene Vector in Genetherapy of Nasopharyngeal Carcinoma , 2007 .
[8] Gui-yuan Li,et al. BRD7 suppresses the growth of Nasopharyngeal Carcinoma cells (HNE1) through negatively regulating β-catenin and ERK pathways , 2007, Molecular and Cellular Biochemistry.
[9] L. You,et al. Wnt inhibitory factor inhibits lung cancer cell growth. , 2007, The Journal of thoracic and cardiovascular surgery.
[10] Ying Liang,et al. Activation of DNA methyltransferase 1 by EBV LMP1 Involves c-Jun NH(2)-terminal kinase signaling. , 2006, Cancer research.
[11] M. Hirashima,et al. Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral Latent Membrane Protein 1 and the immunomodulatory protein galectin 9 , 2006, BMC Cancer.
[12] B. O'Sullivan,et al. Prognostic Significance of the Epstein-Barr Virus, p53, Bcl-2, and Survivin in Nasopharyngeal Cancer , 2006, Clinical Cancer Research.
[13] A. Pinto,et al. Mechanisms of cell immortalization mediated by EB viral activation of telomerase in nasopharyngeal carcinoma , 2006, Cell Research.
[14] P. Meltzer,et al. Molecular and cytogenetic changes involved in the immortalization of nasopharyngeal epithelial cells by telomerase , 2006, International journal of cancer.
[15] H. Dralle,et al. CpG island methylation of tumor-related promoters occurs preferentially in undifferentiated carcinoma. , 2006, Thyroid : official journal of the American Thyroid Association.
[16] E. Rosenthal,et al. Matrix metalloproteases in head and neck cancer. , 2006, Head & neck.
[17] N. Raab-Traub,et al. LMP1 Strain Variants: Biological and Molecular Properties , 2006, Journal of Virology.
[18] Z. Zeng,et al. Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression , 2006, Journal of cellular biochemistry.
[19] Xiaoling Li,et al. Cloning and characterization of the BRD7 gene promoter. , 2006, DNA and cell biology.
[20] W. Xiong,et al. Differential expression of Epstein-Barr virus-encoded RNA and several tumor-related genes in various types of nasopharyngeal epithelial lesions and nasopharyngeal carcinoma using tissue microarray analysis. , 2006, Human pathology.
[21] Cheng-Ta Yang,et al. Wnt signaling activation and WIF-1 silencing in nasopharyngeal cancer cell lines. , 2006, Biochemical and biophysical research communications.
[22] Y. Lau,et al. Epstein-Barr virus infection alters cellular signal cascades in human nasopharyngeal epithelial cells. , 2006, Neoplasia.
[23] Xiaoqiu Chen,et al. [The relationship between hypermethylation of the PTEN promoter and laryngeal squamous cell carcinoma]. , 2006, Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology.
[24] Kim Js,et al. The association between CD99 and LMP-1 expression in nasopharyngeal carcinoma. , 2006 .
[25] K. Miyazaki,et al. The significance of aberrant CHFR methylation for clinical response to microtubule inhibitors in gastric cancer , 2006, Journal of Gastroenterology.
[26] H. Yao,et al. Prognostic Value of Survivin and Livin in Nasopharyngeal Carcinoma , 2006, The Laryngoscope.
[27] T. Golub,et al. Epstein-Barr-Virus-Encoded LMP2A Induces Primary Epithelial Cell Migration and Invasion: Possible Role in Nasopharyngeal Carcinoma Metastasis , 2005, Journal of Virology.
[28] Karin Milde-Langosch,et al. The Fos family of transcription factors and their role in tumourigenesis. , 2005, European journal of cancer.
[29] Y. Tao,et al. Latent membrane protein 1 encoded by Epstein-Barr virus modulates directly and synchronously cyclin D1 and p16 by newly forming a c-Jun/Jun B heterodimer in nasopharyngeal carcinoma cell line. , 2005, Virus research.
[30] N. Raab-Traub,et al. Epstein–Barr virus latent membrane protein 1 CTAR1 mediates rodent and human fibroblast transformation through activation of PI3K , 2005, Oncogene.
[31] Wei Shi,et al. Multiple dysregulated pathways in nasopharyngeal carcinoma revealed by gene expression profiling. , 2005, International journal of cancer.
[32] Minrong Ai,et al. Regulation of Survivin and CDK4 by Epstein-Barr virus encoded latent membrane protein 1 in nasopharyngeal carcinoma cell lines , 2005, Cell Research.
[33] B. Ma,et al. Celecoxib induces dose dependent growth inhibition in nasopharyngeal carcinoma cell lines independent of cyclooxygenase-2 expression. , 2005, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[34] Y. Tao,et al. Epstein-Barr virus encoded latent membrane protein 1 modulates nuclear translocation of telomerase reverse transcriptase protein by activating nuclear factor-kappaB p65 in human nasopharyngeal carcinoma cells. , 2005, The international journal of biochemistry & cell biology.
[35] Chih-Hung Hsu,et al. Inhibitors of Epidermoid Growth Factor Receptor Suppress Cell Growth and Enhance Chemosensitivity of Nasopharyngeal Cancer Cells in vitro , 2005, Oncology.
[36] H. Cheung,et al. Epigenetic inactivation of CHFR in nasopharyngeal carcinoma through promoter methylation , 2005, Molecular carcinogenesis.
[37] M. Schell,et al. Epstein‐Barr virus latent membrane protein 1 induces the matrix metalloproteinase‐1 promoter via an Ets binding site formed by a single nucleotide polymorphism: Enhanced susceptibility to nasopharyngeal carcinoma , 2005, International journal of cancer.
[38] J. Sham,et al. Nasopharyngeal carcinoma , 2005, The Lancet.
[39] F. Tang,et al. Epstein-Barr virus LMP1 initiates cell proliferation and apoptosis inhibition via regulating expression of Survivin in nasopharyngeal carcinoma. , 2005, Experimental oncology.
[40] Biao He,et al. Wnt signaling in lung cancer. , 2005, Cancer letters.
[41] T. Putti,et al. Cyclooxygenase 2 expression in nasopharyngeal carcinoma: immunohistochemical findings and potential implications , 2005, Journal of Clinical Pathology.
[42] Amie Y Lee,et al. Blockade of Wnt-1 signaling induces apoptosis in human colorectal cancer cells containing downstream mutations , 2005, Oncogene.
[43] Y. Tao,et al. [Cross-talk between c-Jun/Ets1 involved in EB virus-encoded latent membrane protein 1 regulates expression of matrix metalloproteinase-9 in nasopharyngeal carcinoma]. , 2005, Zhonghua zhong liu za zhi [Chinese journal of oncology].
[44] Cristina M. Pinto,et al. Retracted: Frequent genetic and biochemical alterations of the PI 3‐K/AKT/PTEN pathway in head and neck squamous cell carcinoma , 2005, International journal of cancer.
[45] B. Steinberg,et al. Phosphatidylinositol 3-kinase regulates early differentiation in human laryngeal keratinocytes , 2005, In Vitro Cellular & Developmental Biology - Animal.
[46] N. Raab-Traub,et al. Roles of the ITAM and PY Motifs of Epstein-Barr Virus Latent Membrane Protein 2A in the Inhibition of Epithelial Cell Differentiation and Activation of β-Catenin Signaling , 2005, Journal of Virology.
[47] Y. Tao,et al. Nuclear accumulation of epidermal growth factor receptor and acceleration of G1/S stage by Epstein-Barr-encoded oncoprotein latent membrane protein 1. , 2005, Experimental cell research.
[48] Y. Kudo,et al. Down-regulation of Cdk inhibitor p27 in oral squamous cell carcinoma. , 2005, Oral oncology.
[49] B. Goh,et al. Overexpression of cyclooxygenase-2 in nasopharyngeal carcinoma and association with epidermal growth factor receptor expression. , 2005, Archives of otolaryngology--head & neck surgery.
[50] I. Ernberg,et al. Epstein‐Barr virus latent membrane 2A (LMP2A) down‐regulates telomerase reverse transcriptase (hTERT) in epithelial cell lines , 2005, International journal of cancer.
[51] S. Bao,et al. The activation of Akt/PKB signaling pathway and cell survival , 2005, Journal of cellular and molecular medicine.
[52] Jen-Kuo Hwang,et al. MDM2 expression in EBV-infected nasopharyngeal carcinoma cells , 2004, Laboratory Investigation.
[53] J. Curnow,et al. Epstein-Barr virus-encoded LMP2A regulates viral and cellular gene expression by modulation of the NF-kappaB transcription factor pathway. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[54] Hui-ying Yu,et al. [Effects of basic fibroblast growth factor on protein kinase B activity and c-fos expression in CNE- I nasopharyngeal carcinoma cell line]. , 2004, Zhonghua er bi yan hou ke za zhi.
[55] X. Huo,et al. [Expression and significance of PTEN in nasopharyngeal carcinoma]. , 2004, Lin chuang er bi yan hou ke za zhi = Journal of clinical otorhinolaryngology.
[56] N. Raab-Traub,et al. Accumulation of Cytoplasmic β-Catenin and Nuclear Glycogen Synthase Kinase 3β in Epstein-Barr Virus-Infected Cells , 2004, Journal of Virology.
[57] Y. Tao,et al. Heterodimer formation between c-Jun and Jun B proteins mediated by Epstein-Barr virus encoded latent membrane protein 1. , 2004, Cellular signalling.
[58] Mu-Kuan Chen,et al. Expression of p53 protein and primary tumour volume in patients with nasopharyngeal carcinoma. , 2004, The Journal of otolaryngology.
[59] X. Deng,et al. Telomerase activation by Epstein-Barr virus latent membrane protein 1 is associated with c-Myc expression in human nasopharyngeal epithelial cells. , 2004, Journal of experimental & clinical cancer research : CR.
[60] Yi Ren,et al. Association of E-cadherin and beta-catenin with metastasis in nasopharyngeal carcinoma. , 2004, Chinese medical journal.
[61] M. Gulley,et al. Differential Signaling Pathways Are Activated in the Epstein-Barr Virus-Associated Malignancies Nasopharyngeal Carcinoma and Hodgkin Lymphoma , 2004, Cancer Research.
[62] J Silvio Gutkind,et al. Global Gene Expression Profile of Nasopharyngeal Carcinoma by Laser Capture Microdissection and Complementary DNA Microarrays , 2004, Clinical Cancer Research.
[63] H. Hsu,et al. Cooperative interactions among p53, bcl‐2 and Epstein–Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells , 2004, Pathology international.
[64] W. Xiong,et al. BRD7, a novel bromodomain gene, inhibits G1–S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways , 2004, Journal of cellular physiology.
[65] Y. Kwong,et al. Clinicopathologic significance of plasma matrix metalloproteinase-2 and -9 levels in patients with undifferentiated nasopharyngeal carcinoma. , 2004, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[66] E. Ioachim,et al. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features. , 2004, Journal of experimental & clinical cancer research : CR.
[67] T. Yoshizaki,et al. Epstein‐Barr Virus (EBV) Latent Membrane Protein 1 Induces Interleukin‐8 through the Nuclear Factor‐κB Signaling Pathway in EBV‐Infected Nasopharyngeal Carcinoma Cell Line , 2004, The Laryngoscope.
[68] S. Akira,et al. Elucidation of the c-Jun N-Terminal Kinase Pathway Mediated by Epstein-Barr Virus-Encoded Latent Membrane Protein 1 , 2004, Molecular and Cellular Biology.
[69] M.D.,et al. Prognostic Role of Ebstein-Barr Virus Latent Membrane Protein-1 and Interleukin-10 Expression in Patients with Nasopharyngeal Carcinoma , 2004 .
[70] Pauline Chu,et al. Essential requirement for Wnt signaling in proliferation of adult small intestine and colon revealed by adenoviral expression of Dickkopf-1 , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[71] Mong-Hong Lee,et al. Regulators of G1 cyclin–dependent kinases and cancers , 2003, Cancer and Metastasis Reviews.
[72] W. Hung,et al. RECK is a target of Epstein–Barr virus latent membrane protein 1 , 2003, Oncogene.
[73] Jiang Li,et al. Expression of tumor related genes NGX6, NAG-7, BRD7 in gastric and colorectal cancer. , 2003, World journal of gastroenterology.
[74] E. Hara,et al. Epstein-Barr virus LMP1 blocks p16INK4a–RB pathway by promoting nuclear export of E2F4/5 , 2003, The Journal of cell biology.
[75] J. Schouten,et al. Delineating genetic pathways of disease progression in head and neck squamous cell carcinoma. , 2003, Archives of otolaryngology--head & neck surgery.
[76] K. Schuebel,et al. Epigenetic inactivation of CHFR in human tumors , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[77] R. Gilbert,et al. Loss of p16 expression has prognostic significance in human nasopharyngeal carcinoma. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.
[78] Y. Wong,et al. Alterations of Biologic Properties and Gene Expression in Nasopharyngeal Epithelial Cells by the Epstein-Barr Virus–Encoded Latent Membrane Protein 1 , 2003, Laboratory Investigation.
[79] Tim Crook,et al. The p53 network in head and neck cancer. , 2003, Oral oncology.
[80] L. Hutt-Fletcher,et al. A Positive Autoregulatory Loop of LMP1 Expression and STAT Activation in Epithelial Cells Latently Infected with Epstein-Barr Virus , 2003, Journal of Virology.
[81] D. Crawford,et al. Epstein-Barr virus-recent advances. , 2003, The Lancet. Infectious diseases.
[82] F. Fang,et al. Low expression levels of p27 correlate with loco-regional recurrence in nasopharyngeal carcinoma. , 2003, Cancer letters.
[83] K. Lo,et al. Genetic and epigenetic changes in nasopharyngeal carcinoma. , 2002, Seminars in cancer biology.
[84] A. Lin,et al. The Absence of NF-κB-Mediated Inhibition of c-Jun N-Terminal Kinase Activation Contributes to Tumor Necrosis Factor Alpha-Induced Apoptosis , 2002, Molecular and Cellular Biology.
[85] L. Matrisian,et al. Matrix metalloproteinases in tumor-host cell communication. , 2002, Differentiation; research in biological diversity.
[86] Stefania Staibano,et al. Expression of epidermal growth factor receptor correlates with disease relapse and progression to androgen-independence in human prostate cancer. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[87] C. Hwang,et al. Loss of cyclin D1 and p16 expression correlates with local recurrence in nasopharyngeal carcinoma following radiotherapy. , 2002, Annals of oncology : official journal of the European Society for Medical Oncology.
[88] S. V. Anisimov,et al. Targets of c-Jun NH(2)-terminal kinase 2-mediated tumor growth regulation revealed by serial analysis of gene expression. , 2002, Cancer research.
[89] E. K. Parkinson,et al. Telomerase inhibition and the future management of head-and-neck cancer. , 2002, The Lancet. Oncology.
[90] Brian David Dynlacht,et al. E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex. , 2002, Genes & development.
[91] D. Wong,et al. Expression of cell cycle control proteins in normal epithelium, premalignant and malignant lesions of oral cavity. , 2002, Oral oncology.
[92] Michael Karin,et al. NF-κB in cancer: from innocent bystander to major culprit , 2002, Nature Reviews Cancer.
[93] M. Hurle,et al. Chfr regulates a mitotic stress pathway through its RING-finger domain with ubiquitin ligase activity. , 2002, Cancer research.
[94] C. Dang,et al. Translocations involving c-myc and c-myc function , 2001, Oncogene.
[95] M. Chang,et al. Association of p53 and BCL‐2 expression with Epstein‐Barr virus infection in the cancers of head and neck , 2001, Head & neck.
[96] M. Sunagawa,et al. Expression of p16, nm23‐H1, E‐cadherin, and CD44 Gene Products and Their Significance in Nasopharyngeal Carcinoma , 2001, The Laryngoscope.
[97] H. Namba,et al. Involvement of wild-type p53 in radiation-induced c-Jun N-terminal kinase activation in human thyroid cells. , 2001, Anticancer research.
[98] H. Namba,et al. Transient activation of c-Jun NH2-terminal kinase by growth factors influences survival but not apoptosis of human thyrocytes. , 2001, Thyroid : official journal of the American Thyroid Association.
[99] G. Dong,et al. IL (Interleukin)-1α Promotes Nuclear Factor-κB and AP-1-induced IL-8 Expression, Cell Survival, and Proliferation in Head and Neck Squamous Cell Carcinomas , 2001 .
[100] T. Yoshizaki,et al. Induction of cyclooxygenase-2 by Epstein–Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[101] G. Wang,et al. [Expression of telomerase subunits and its relationship with telomerase activity in nasopharyngeal carcinoma]. , 2001, Zhonghua yi xue za zhi.
[102] C. Van Waes,et al. Coexpression of proangiogenic factors IL-8 and VEGF by human head and neck squamous cell carcinoma involves coactivation by MEK-MAPK and IKK-NF-kappaB signal pathways. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[103] Marc Schmidt,et al. Ras-independent Activation of the Raf/MEK/ERK Pathway upon Calcium-induced Differentiation of Keratinocytes* , 2000, The Journal of Biological Chemistry.
[104] S. H. Cheng,et al. Long-term survival of nasopharyngeal carcinoma following concomitant radiotherapy and chemotherapy. , 2000, International journal of radiation oncology, biology, physics.
[105] I. Stamenkovic. Matrix metalloproteinases in tumor invasion and metastasis. , 2000, Seminars in cancer biology.
[106] S. Maeda,et al. Co-expression of p53 and bcl-2 may correlate to the presence of epstein-barr virus genome and the expression of proliferating cell nuclear antigen in nasopharyngeal carcinoma. , 2000, Cancer letters.
[107] S. Elledge,et al. The DNA damage response: putting checkpoints in perspective , 2000, Nature.
[108] T. Halazonetis,et al. Chfr defines a mitotic stress checkpoint that delays entry into metaphase , 2000, Nature.
[109] T. Crook,et al. High level expression of ΔN-p63: a mechanism for the inactivation of p53 in undifferentiated nasopharyngeal carcinoma (NPC)? , 2000, Oncogene.
[110] Liangguo Xu,et al. Identification of differentially expressed genes in nasopharyngeal carcinoma by means of the Atlas human cancer cDNA expression array , 2000, Journal of Cancer Research and Clinical Oncology.
[111] S. Dey,et al. Host cyclooxygenase-2 modulates carcinoma growth. , 2000, The Journal of clinical investigation.
[112] M. Gorospe,et al. Inhibition of c-Jun N-Terminal Kinase 2 Expression Suppresses Growth and Induces Apoptosis of Human Tumor Cells in a p53-Dependent Manner , 2000, Molecular and Cellular Biology.
[113] J F Barrett,et al. Identification of CDK4 as a target of c-MYC. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[114] W. Funkhouser,et al. Selective activation of NF-κB subunits in human breast cancer: potential roles for NF-κB2/p52 and for Bcl-3 , 2000, Oncogene.
[115] I. Koizuka,et al. Absence of Nuclear p16 From Epstein‐Barr Virus‐Associated Undifferentiated Nasopharyngeal Carcinomas , 2000, The Laryngoscope.
[116] N. Y. Chung,et al. Inhibiting tumorigenic potential by restoration of p16 in nasopharyngeal carcinoma , 1999, British Journal of Cancer.
[117] J. Swantek,et al. New insights into the control of MAP kinase pathways. , 1999, Experimental Cell Research.
[118] K. Kawakami,et al. A Selective Cyclooxygenase‐2 Inhibitor Suppresses Tumor Growth in Nude Mouse Xenografted with Human Head and Neck Squamous Carcinoma Cells , 1999, Japanese journal of cancer research : Gann.
[119] S. Reed,et al. Deregulated cyclin E induces chromosome instability , 1999, Nature.
[120] W. Benedict,et al. Expression of p16, Rb, and cyclin D1 gene products in oral and laryngeal squamous carcinoma: biological and clinical implications. , 1999, Human pathology.
[121] A. Hui,et al. Detection of recurrent chromosomal gains and losses in primary nasopharyngeal carcinoma by comparative genomic hybridisation , 1999, International journal of cancer.
[122] Hiroki Sato,et al. Matrix Metalloproteinase 9 Expression Is Induced by Epstein-Barr Virus Latent Membrane Protein 1 C-Terminal Activation Regions 1 and 2 , 1999, Journal of Virology.
[123] E. Prochownik,et al. MYC oncogenes and human neoplastic disease , 1999, Oncogene.
[124] C. Marshall,et al. Activated MEK Stimulates Expression of AP-1 Components Independently of Phosphatidylinositol 3-Kinase (PI3-Kinase) but Requires a PI3-Kinase Signal To Stimulate DNA Synthesis , 1999, Molecular and Cellular Biology.
[125] Fengzhi Li,et al. Control of apoptosis and mitotic spindle checkpoint by survivin , 1998, Nature.
[126] J C Reed,et al. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs. , 1998, Cancer research.
[127] E. Rosenthal,et al. Role of the plasminogen activator and matrix metalloproteinase systems in epidermal growth factor- and scatter factor-stimulated invasion of carcinoma cells. , 1998, Cancer research.
[128] U. Rapp,et al. Cell cycle targets of Ras/Raf signalling , 1998, Oncogene.
[129] Y. Bang,et al. Increased MAPK activity and MKP-1 overexpression in human gastric adenocarcinoma. , 1998, Biochemical and biophysical research communications.
[130] A. Yang,et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. , 1998, Molecular cell.
[131] J. Marks,et al. The national cancer data base report on the relationship of race and national origin to the histology of nasopharyngeal carcinoma , 1998, Cancer.
[132] R. DuBois,et al. Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells , 1998, Cell.
[133] M. Spitz,et al. Alterations of p53, cyclin D1, rb, and H‐ras in human oral carcinomas related to tobacco use , 1998, Cancer.
[134] Tomohiko Maehama,et al. The Tumor Suppressor, PTEN/MMAC1, Dephosphorylates the Lipid Second Messenger, Phosphatidylinositol 3,4,5-Trisphosphate* , 1998, The Journal of Biological Chemistry.
[135] L. Young,et al. Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1) , 1998, Oncogene.
[136] M. Gulley,et al. Nasopharyngeal carcinomas frequently lack the p16/MTS1 tumor suppressor protein but consistently express the retinoblastoma gene product. , 1998, The American journal of pathology.
[137] J. Cooper,et al. Chemoradiotherapy versus radiotherapy in patients with advanced nasopharyngeal cancer: phase III randomized Intergroup study 0099. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[138] Yue Xiong,et al. ARF Promotes MDM2 Degradation and Stabilizes p53: ARF-INK4a Locus Deletion Impairs Both the Rb and p53 Tumor Suppression Pathways , 1998, Cell.
[139] A. E. Rogers,et al. Aberrant nuclear factor-kappaB/Rel expression and the pathogenesis of breast cancer. , 1997, The Journal of clinical investigation.
[140] B. Dörken,et al. Constitutive nuclear factor-kappaB-RelA activation is required for proliferation and survival of Hodgkin's disease tumor cells. , 1997, The Journal of clinical investigation.
[141] Y. F. Poon,et al. Nasopharyngeal carcinoma: presenting symptoms and duration before diagnosis. , 1997, Hong Kong medical journal = Xianggang yi xue za zhi.
[142] W. Ansorge,et al. Cdk2-dependent phosphorylation of p27 facilitates its Myc-induced release from cyclin E/cdk2 complexes , 1997, Oncogene.
[143] L. Matrisian,et al. Changing views of the role of matrix metalloproteinases in metastasis. , 1997, Journal of the National Cancer Institute.
[144] T. Panzarella,et al. Enhanced control by radiotherapy of cervical lymph node metastases arising from nasopharyngeal carcinoma compared with nodal metastases from other head and neck squamous cell carcinomas. , 1997, International journal of radiation oncology, biology, physics.
[145] D. Altieri,et al. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma , 1997, Nature Medicine.
[146] I. McKillop,et al. Increased MAPK expression and activity in primary human hepatocellular carcinoma. , 1997, Biochemical and biophysical research communications.
[147] M. Vasef,et al. Nasopharyngeal Carcinoma, with Emphasis on its Relationship to Epstein-Barr Virus , 1997, The Annals of otology, rhinology, and laryngology.
[148] M. Wigler,et al. PTEN, a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer , 1997, Science.
[149] R. Davis,et al. The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. , 1996, The Journal of biological chemistry.
[150] R. Kerbel,et al. Impact of the cyclin–dependent kinase inhibitor p27Kip1 on resistance of tumor cells to anticancer agents , 1996, Nature Medicine.
[151] A. Franchi,et al. Prediction of occult neck metastases in laryngeal carcinoma: role of proliferating cell nuclear antigen, MIB-1, and E-cadherin immunohistochemical determination. , 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.
[152] J. Bartek,et al. High frequency of p16 (CDKN2/MTS-1/INK4A) inactivation in head and neck squamous cell carcinoma. , 1996, Cancer research.
[153] F. Larcher,et al. Expression of cyclin D1 in epithelial tissues of transgenic mice results in epidermal hyperproliferation and severe thymic hyperplasia. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[154] W. Lee,et al. Down regulation of bcl‐2 by p53 in nasopharyngeal carcinoma and lack of detection of its specific t(14;18) chromosomal translocation in fixed tissues , 1996, Histopathology.
[155] R. Treisman,et al. Regulation of transcription by MAP kinase cascades. , 1996, Current opinion in cell biology.
[156] R. DuBois,et al. Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 , 1995, Cell.
[157] J. Sham,et al. ras mutations are uncommon in nasopharyngeal carcinoma. , 1995, European journal of cancer. Part B, Oral oncology.
[158] O Yoshida,et al. Constitutive activation of mitogen-activated protein (MAP) kinases in human renal cell carcinoma. , 1995, Cancer research.
[159] J. Herman,et al. 5′ CpG island methylation is associated with transcriptional silencing of the tumour suppressor p16/CDKN2/MTS1 in human cancers , 1995, Nature Medicine.
[160] F. Eschwège,et al. Undifferentiated nasopharyngeal cancer (UCNT): current diagnostic and therapeutic aspects. , 1995, International journal of radiation oncology, biology, physics.
[161] W. Nelson,et al. Genetic and biochemical dissection of protein linkages in the cadherin-catenin complex. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[162] R. Weinberg,et al. The retinoblastoma protein and cell cycle control , 1995, Cell.
[163] A. Hart,et al. Overexpression of cyclin D1 correlates with recurrence in a group of forty-seven operable squamous cell carcinomas of the head and neck. , 1995, Cancer research.
[164] J. O'Connell,et al. Reciprocated matrix metalloproteinase activation: a process performed by interstitial collagenase and progelatinase A. , 1994, Biochemistry.
[165] E. Kieff,et al. An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[166] B. Gallie,et al. The retinoblastoma protein and the cell cycle. , 1992, Seminars in cancer biology.
[167] Q Y Yao,et al. Epstein-Barr virus latent gene transcription in nasopharyngeal carcinoma cells: coexpression of EBNA1, LMP1, and LMP2 transcripts , 1992, Journal of virology.
[168] A. Seymour. Histological Typing of Tumours of the Upper Respiratory Tract and Ear , 1991 .
[169] W. Fiers,et al. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role , 1991, Cell.
[170] D. Kondziolka,et al. Stereotactic radiosurgery for squamous cell carcinoma of the nasopharynx , 1991, The Laryngoscope.
[171] R. Schreiber,et al. Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death , 1990, Nature.
[172] E. Kieff,et al. Epstein-Barr virus nuclear antigen 2 transactivates latent membrane protein LMP1 , 1990, Journal of virology.
[173] J. Sham,et al. Detection of subclinical riasopharyngeal carcinoma by fibreoptic endoscopy and multiple biopsy , 1990, The Lancet.
[174] G. Bepler,et al. Epidermal growth factor receptor expression in human lung cancer cell lines. , 1988, Cancer research.
[175] H. Moses,et al. Growth factors and cancer. , 1986, Cancer research.
[176] E. Kieff,et al. An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells , 1985, Cell.
[177] M. Kondo,et al. Squamous cell carcinoma of the nasopharynx. An analysis of failure patterns after radiation therapy. , 1985, Acta radiologica. Oncology.
[178] G. Shklar,et al. Oral mucosal tumor inhibition by ibuprofen. , 1983, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.
[179] R. R. Howe,et al. Distinctive chromosomal abnormalities in histologic subtypes of non-Hodgkin's lymphoma. , 1982, The New England journal of medicine.
[180] J. P. Hansen,et al. Nasopharyngeal cancer in Greenland. The incidence in an Arctic Eskimo population. , 1977, Acta pathologica et microbiologica Scandinavica. Section A, Pathology.
[181] P. Buell. The effect of migration on the risk of nasopharyngeal cancer among Chinese. , 1974, Cancer research.
[182] V. Diehl,et al. Antibodies to Epstein-Barr virus in Burkitt's lymphoma and control groups. , 1969, Journal of the National Cancer Institute.
[183] Zhe Zhang,et al. Inactivation of RASSF2A by promoter methylation correlates with lymph node metastasis in nasopharyngeal carcinoma , 2007, International journal of cancer.
[184] Z. Zeng,et al. Gene expression profiling of nasopharyngeal carcinoma reveals the abnormally regulated Wnt signaling pathway. , 2007, Human pathology.
[185] Yuxiang He,et al. Role of enhanced radiosensitivity and the tumor-specific suicide gene vector in gene therapy of nasopharyngeal carcinoma. , 2007, Journal of radiation research.
[186] Wen-Qi Jiang,et al. [Significance of EGFR and p-ERK expression in nasopharyngeal carcinoma]. , 2006, Zhonghua zhong liu za zhi [Chinese journal of oncology].
[187] M. C. Lee,et al. The association between CD99 and LMP-1 expression in nasopharyngeal carcinoma. , 2006, Experimental oncology.
[188] J. Burgos. Involvement of the epstein-barr virus in the nasopharyngeal carcinoma pathogenesis , 2005, Medical oncology.
[189] K. Marumo,et al. Inhibition of Wnt signaling downregulates Akt activity and induces chemosensitivity in PTEN‐mutated prostate cancer cells , 2005, The Prostate.
[190] Massimo Loda,et al. Role of p27 in Prostate Carcinogenesis , 2004, Cancer and Metastasis Reviews.
[191] Ching‐Hwa Tsai,et al. Regulation of matrix metalloproteinase-1 by Epstein-Barr virus proteins. , 2003, Cancer research.
[192] Ya Cao,et al. Cells in G2/M phase increased in human nasopharyngeal carcinoma cell line by EBV-LMP1 through activation of NF-κB and AP-1 , 2003, Cell Research.
[193] C. Harris,et al. Rapid Akt activation by nicotine and a tobacco carcinogen modulates the phenotype of normal human airway epithelial cells. , 2003, The Journal of clinical investigation.
[194] T. West,et al. HLA associations with nasopharyngeal carcinoma in Southern Chinese: a meta-analysis. , 2002, Clinical otolaryngology and allied sciences.
[195] J. Rubin,et al. Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas , 2002, Oncogene.
[196] P. Johnson,et al. Promoter hypermethylation of multiple genes in nasopharyngeal carcinoma. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[197] B. Fingleton,et al. Matrilysin [MMP-7] expression selects for cells with reduced sensitivity to apoptosis. , 2001, Neoplasia.
[198] Y. Nagashima,et al. Reduced expression of p16 and p27 proteins in nasopharyngeal carcinoma. , 2001, Cancer detection and prevention.
[199] Q. Chen,et al. Homozygous deletion of the PTEN tumor-suppressor gene is not a feature in oral squamous cell carcinoma. , 2000, Oral oncology.
[200] C. Sherr. Cell cycle control and cancer. , 2000, Harvey lectures.
[201] 堀川 利之. Association of Latent Membrane Protein 1 and Matrix Metalloproteinase 9 with Metastasis in Nasopharyngeal Carcinoma , 2000 .
[202] J. Abbruzzese,et al. The nuclear factor-kappa B RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.
[203] A. Hill,et al. Lack of correlation between G1 arrest and radiation age-response in three synchronized human tumour cell lines. , 1999, International journal of radiation biology.
[204] Douglas B. Evans,et al. The Nuclear Factor-κB RelA Transcription Factor Is Constitutively Activated in Human Pancreatic Adenocarcinoma Cells , 1999 .
[205] 李晓燕,et al. Detection of c-myc gene expression in nasopharyngeal carcinoma by nonradioactive in situ hybridization and immunohistochemistry , 1997 .
[206] G. Cooper. The Cell: A Molecular Approach , 1996 .
[207] D. Spandidos,et al. The detection of the c-myc and ras oncogenes in nasopharyngeal carcinoma by immunohistochemistry. , 1994, Acta oto-laryngologica.
[208] D M Parkin,et al. Cancer Incidence in Five Continents. Comparability and quality of data. , 1992, IARC scientific publications.
[209] Parkin Dm,et al. Cancer Incidence in Five Continents. Comparability and quality of data. , 1992 .
[210] D. Choy,et al. Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients. , 1990, The British journal of radiology.
[211] W. McGuire,et al. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. , 1987, Science.
[212] J. Yates,et al. Stable replication of plasmids derived from Epstein–Barr virus in various mammalian cells , 1985, Nature.
[213] B. Henderson,et al. Nasopharyngeal carcinoma in Chinese---salted fish or inhaled smoke? , 1981, Preventive medicine.